Global Health (India) Performance
| MEDANTA Stock | 1,076 0.20 0.02% |
The company retains a Market Volatility (i.e., Beta) of 0.1, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Global Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Global Health is expected to be smaller as well. At this point, Global Health Limited has a negative expected return of -0.0618%. Please make sure to check out Global Health's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to decide if Global Health Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Global Health Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Global Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Global Health Limited Strengthens Leadership with New Appointment - TipRanks | 10/30/2024 |
2 | Up 225 percent in two years Is this multibagger hospital stock worth buying post Q2 show - Business Today | 11/19/2024 |
| Begin Period Cash Flow | 7.7 B |
Global |
Global Health Relative Risk vs. Return Landscape
If you would invest 112,965 in Global Health Limited on August 31, 2024 and sell it today you would lose (5,330) from holding Global Health Limited or give up 4.72% of portfolio value over 90 days. Global Health Limited is generating negative expected returns and assumes 1.8158% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Global, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Global Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Global Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Global Health Limited, and traders can use it to determine the average amount a Global Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.034
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MEDANTA |
Estimated Market Risk
| 1.82 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Global Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Global Health by adding Global Health to a well-diversified portfolio.
Global Health Fundamentals Growth
Global Stock prices reflect investors' perceptions of the future prospects and financial health of Global Health, and Global Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Global Stock performance.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.093 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 285.86 B | ||||
| Shares Outstanding | 268.55 M | ||||
| Price To Book | 9.20 X | ||||
| Price To Sales | 8.60 X | ||||
| Revenue | 32.75 B | ||||
| Gross Profit | 13.74 B | ||||
| EBITDA | 8.72 B | ||||
| Net Income | 4.78 B | ||||
| Total Debt | 8.02 B | ||||
| Book Value Per Share | 108.21 X | ||||
| Cash Flow From Operations | 6.12 B | ||||
| Earnings Per Share | 18.19 X | ||||
| Total Asset | 43.04 B | ||||
| Retained Earnings | 17.64 B | ||||
About Global Health Performance
By analyzing Global Health's fundamental ratios, stakeholders can gain valuable insights into Global Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Global Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Global Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Global Health is entity of India. It is traded as Stock on NSE exchange.Things to note about Global Health Limited performance evaluation
Checking the ongoing alerts about Global Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Global Health Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Global Health generated a negative expected return over the last 90 days | |
| Global Health is unlikely to experience financial distress in the next 2 years | |
| About 68.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Up 225 percent in two years Is this multibagger hospital stock worth buying post Q2 show - Business Today |
- Analyzing Global Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Global Health's stock is overvalued or undervalued compared to its peers.
- Examining Global Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Global Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Global Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Global Health's stock. These opinions can provide insight into Global Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Global Stock analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Transaction History View history of all your transactions and understand their impact on performance |